Susanna Lamers

Our recent publication compares genetic diversity in commercially available AAV products using three different sequencing methods. Read Here

Quantifying DNA point mutations in commercially available AAV reporter vectors.  Rebecca Rose, David J. Nolan, Jonathan A. DaRoza, Sanford L.

ASPR/BARDA awards $500 million for Project NextGen technologies that advance innovative next-generation vaccine and therapeutics platforms. BioInfoExperts is among the recipients, with $4 million to provide genomic sequencing of COVID-19.

Cloudticity provides BIE with protocols that assist BIE in protecting against cybersecurity threats to ensure our technologies meet the compliance requirements of today and tomorrow.

BIE is aggressively entering the gene therapy manufacturing industry where they will genetically characterize viral vector-based products, like rAAVs.

Dr. Chenzhong Li of Tulane University and Susanna Lamers, CEO of BioInfoExperts, talk about their breakthrough technologies on WWNO’s NPR broadcast of “Out to Lunch”.

The “BIE Underwrites Genome Sequencing” (B.U.G.S) funding will provide whole pathogen genome sequencing and analysis for up to 35 de-identified pathogen samples.

BioInfoExperts is part of the Louisiana Economic Development (LED) state-wide initiative to strengthen business and economic opportunities.

Scientists from BioInfoExperts LLC (BIE) and Ochsner Health have completed the first whole genome sequences of the SARS-CoV-2 coronavirus from the New Orleans area.

More than 80 startups funded by the U.S. National Science Foundation are creating technology solutions to enhance the detection and treatment of COVID-19.